Neon Therapeutics is based out of Cambridge. Neon Therapeutics, Inc. operates as a biotechnology company. The Company offers a neoantigen platform to develop neoantigen-targeted therapies for the treatment of cancer by directing the immune system. Neon Therapeutics offers its services in the United States. The firm last filed a Form D notice of exempt offering of securities on 2017-12-13. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Neon Therapeutics, Inc.40 ERIE STREET
CAMBRIDGE MA 02139
Business Phone: 617-337-4701
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)